Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Renhe Capital

Founders Weichun Jin

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 23
Average round size
info
The average size of a deal this fund participated in
$3M
Portfolio companies 22
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.04
Exits 6
Key employees 2
Stages of investment
Private Equity

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Pharmaceutical
Summary

The company was established in Asia in China. The main office of represented VC is situated in the Shenzhen.

The current fund was established by Weichun Jin.

The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 1 - 5 millions dollars. The high activity for fund was in 2018.

The usual cause for the fund is to invest in rounds with 1 partaker.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. We can highlight the next thriving fund investment areas, such as Medical Device, Health Care. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Kangso Medical Inspection.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Renhe Capital:
Typical Co-investors
Renhe Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Renhe Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Blue Slide Ventures New York, New York, United States
BrilliMedical International Corporation -
Cox Orange Investment Ltd Canada, Lions Head, Ontario
Faering Capital India, Maharashtra, Mumbai
Flashstarts Cleveland, Ohio, United States
GiDi Venture Capital Lagos, Lagos, Nigeria
Innalabs Holding Dulles, United States, Virginia
Innovation Fund Macedonia -
International Securities Exchange Holdings New York, New York, United States
Meaningful Partners California, El Segundo, United States
Monex Precious Metals California, Newport Beach, United States
NewBornTown Beijing, Beijing, China
Omicron Media Florida, United States, Winter Park
Patria Mobile -
Powershift Group Austin, Texas, United States
Sa Sa International Holdings -
Sinvo Group Beijing, China, Haidian
United Capital China, Fujian, Hunan
ZCash Foundation -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Kunhua Technology

Energy Storage
Fuel Cell
$15M03 Jul 2023 Jiading, Shanghai, China

Furong Biotech

Biotechnology
Medical
Pharmaceutical
$15M06 Feb 2023 Suzhou, Jiangsu, China

Zezheng Pharmaceutical

Biopharma
Biotechnology
Health Care
Pharmaceutical
$15M27 Dec 2021 Jiading, Shanghai, China

Kangso Medical Inspection

Biotechnology
Health Care
Medical
Medical Device
$2M20 Aug 2018 China, Beijing

Artificial Intelligence
Big Data
Cloud Computing
$1M01 Jul 2016 China, Shanghai

Biotechnology
Health Care
Medical Device
$15M12 Jun 2015 China, Beijing

HUNAN TEA GROUP CO.,LTD

Consumer
Food and Beverage
Tea
$1M24 Dec 2013 Tianxin District, Hunan

Medicilon

Biopharma
Health Care
Medical
$3M01 Jan 2013 Shanghai, China

Dream

Gaming
Media and Entertainment
Software
$3M18 Jul 2012 Changning District, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Renhe Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 23
Average round size 3M
Peak activity year 2016
Lead investments 3
Follow on index 0.04
Exits 6
Group Appearance index 0.26

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Kunhua Technology

Energy Storage
Fuel Cell
$15M03 Jul 2023 Jiading, Shanghai, China

Furong Biotech

Biotechnology
Medical
Pharmaceutical
$15M06 Feb 2023 Suzhou, Jiangsu, China

Zezheng Pharmaceutical

Biopharma
Biotechnology
Health Care
Pharmaceutical
$15M27 Dec 2021 Jiading, Shanghai, China

Kangso Medical Inspection

Biotechnology
Health Care
Medical
Medical Device
$2M20 Aug 2018 China, Beijing

Artificial Intelligence
Big Data
Cloud Computing
$1M01 Jul 2016 China, Shanghai

Biotechnology
Health Care
Medical Device
$15M12 Jun 2015 China, Beijing

HUNAN TEA GROUP CO.,LTD

Consumer
Food and Beverage
Tea
$1M24 Dec 2013 Tianxin District, Hunan

Medicilon

Biopharma
Health Care
Medical
$3M01 Jan 2013 Shanghai, China

Dream

Gaming
Media and Entertainment
Software
$3M18 Jul 2012 Changning District, China
Crunchbase icon

Content report

The following text will be sent to our editors: